The ongoing antigenic evolution of SARS-CoV-2, particularly within the spike glycoprotein, threatens the long-term efficacy of spike-focused vaccines and serodiagnostics. While most authorized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results